Eli Lilly (LLY) and the World Health Organization Foundation said Monday that they are collaborating to support the WHO's global action plan on the public response to dementia.
The support will boost efforts to reduce dementia risks, early detection, diagnosis and care, they said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.